Mi Kwon Son

1.5k total citations
41 papers, 830 citations indexed

About

Mi Kwon Son is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mi Kwon Son has authored 41 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 15 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Mi Kwon Son's work include PI3K/AKT/mTOR signaling in cancer (10 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Mi Kwon Son is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (10 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Mi Kwon Son collaborates with scholars based in South Korea, China and Singapore. Mi Kwon Son's co-authors include Kyung Hee Jung, Soon‐Sun Hong, Hong Yan, Hyunseung Lee, Sungwoo Hong, Zhenghuan Fang, Hee Seung Lee, Hee‐Seung Lee, Jung Hee Park and Soo‐Jeong Kim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Mi Kwon Son

40 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mi Kwon Son South Korea 18 418 302 132 89 79 41 830
Li-Yuan Bai Taiwan 17 466 1.1× 150 0.5× 99 0.8× 109 1.2× 82 1.0× 42 869
Lantu Gou China 20 547 1.3× 403 1.3× 138 1.0× 100 1.1× 65 0.8× 56 1.1k
Xianzhi Meng China 15 500 1.2× 208 0.7× 242 1.8× 79 0.9× 38 0.5× 28 861
Haolan Wang China 6 520 1.2× 251 0.8× 192 1.5× 65 0.7× 42 0.5× 9 861
Haijun Zhang China 15 544 1.3× 211 0.7× 229 1.7× 56 0.6× 70 0.9× 24 870
Dongkyoo Park United States 14 545 1.3× 287 1.0× 137 1.0× 66 0.7× 26 0.3× 19 802
Zhiyi Liu China 11 319 0.8× 308 1.0× 137 1.0× 40 0.4× 35 0.4× 16 656
Céline Van Themsche Canada 18 544 1.3× 246 0.8× 228 1.7× 41 0.5× 36 0.5× 25 894
Sanchita Rauth United States 18 558 1.3× 378 1.3× 204 1.5× 59 0.7× 40 0.5× 36 962

Countries citing papers authored by Mi Kwon Son

Since Specialization
Citations

This map shows the geographic impact of Mi Kwon Son's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Kwon Son with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Kwon Son more than expected).

Fields of papers citing papers by Mi Kwon Son

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi Kwon Son. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Kwon Son. The network helps show where Mi Kwon Son may publish in the future.

Co-authorship network of co-authors of Mi Kwon Son

This figure shows the co-authorship network connecting the top 25 collaborators of Mi Kwon Son. A scholar is included among the top collaborators of Mi Kwon Son based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi Kwon Son. Mi Kwon Son is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Son, Mi Kwon, In Man Kang, Yuri Choi, et al.. (2025). Metal-phenolic networks reverse the immunosuppressive tumor microenvironment via dual metabolism regulation and immunogenic cell death. Journal of Controlled Release. 383. 113775–113775. 2 indexed citations
2.
Lee, Ji Eun, Yeo Wool Kang, Kyung Hee Jung, et al.. (2021). Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape. Cancer Letters. 507. 97–111. 11 indexed citations
3.
Yan, Hong, Kyung Hee Jung, Ji Eun Lee, et al.. (2021). ANGPTL4 accelerates KRASG12D-Induced acinar to ductal metaplasia and pancreatic carcinogenesis. Cancer Letters. 519. 185–198. 20 indexed citations
4.
Jung, Kyung Hee, Mi Kwon Son, Hong Yan, et al.. (2020). ANGPTL 4 exacerbates pancreatitis by augmenting acinar cell injury through upregulation of C5a. EMBO Molecular Medicine. 12(8). e11222–e11222. 23 indexed citations
5.
Lee, Seul Ji, Haiping Wang, Soo Hyun Ahn, et al.. (2019). Metabolomics Approach Based on Multivariate Techniques for Blood Transfusion Reactions. Scientific Reports. 9(1). 1740–1740. 6 indexed citations
6.
Kang, Yeo Wool, Ji Eun Lee, Kyung Hee Jung, et al.. (2018). KRAS targeting antibody synergizes anti-cancer activity of gemcitabine against pancreatic cancer. Cancer Letters. 438. 174–186. 39 indexed citations
7.
Son, Mi Kwon, et al.. (2018). Abstract 871: BR101801: A first-in-class dual inhibitor of PI3Kδ and DNA-PK in non-Hodgkin's lymphoma. Cancer Research. 78(13_Supplement). 871–871.
8.
9.
Kim, Soo Jung, Kyung Hee Jung, Mi Kwon Son, et al.. (2017). Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery. Cancer Letters. 403. 339–353. 51 indexed citations
10.
Yun, Sun‐Mi, Kyung Hee Jung, Soo‐Jeong Kim, et al.. (2014). HS-438, a new inhibitor of Imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia. Cancer Letters. 348(1-2). 50–60. 15 indexed citations
11.
Jung, Kyung Hee, TacGhee Yi, Mi Kwon Son, Sun U. Song, & Soon‐Sun Hong. (2014). Therapeutic effect of human clonal bone marrow-derived mesenchymal stem cells in severe acute pancreatitis. Archives of Pharmacal Research. 38(5). 742–751. 31 indexed citations
12.
Jung, Kyung Hee, Hong Yan, Zhenghuan Fang, et al.. (2014). HS-104, a PI3K inhibitor, enhances the anticancer efficacy of gemcitabine in pancreatic cancer. International Journal of Oncology. 45(1). 311–321. 10 indexed citations
13.
Jung, Kyung Hee, Mi Kwon Son, Hong Yan, et al.. (2013). Anti-cancer effect of HS-345, a new tropomyosin-related kinase A inhibitor, on human pancreatic cancer. Cancer Letters. 338(2). 271–281. 16 indexed citations
14.
Jung, Kyung Hee, Hee‐Seung Lee, Hyunseung Lee, et al.. (2013). A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie’s plaques. International Journal of Oncology. 42(6). 2001–2008. 9 indexed citations
15.
Yun, Sun‐Mi, Kyung Hee Jung, Hyunseung Lee, et al.. (2013). Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cells. Cancer Letters. 331(2). 250–261. 28 indexed citations
16.
Jung, Kyung Hee, Hee‐Seung Lee, Mi Kwon Son, et al.. (2013). SB365, Pulsatilla saponin D, targets c-Met and exerts antiangiogenic and antitumor activities. Carcinogenesis. 34(9). 2156–2169. 34 indexed citations
17.
Son, Mi Kwon, Kyung Hee Jung, Hee Seung Lee, et al.. (2013). SB365, Pulsatilla saponin D suppresses proliferation and induces apoptosis of pancreatic cancer cells. Oncology Reports. 30(2). 801–808. 34 indexed citations
18.
Son, Mi Kwon, Kyung Hee Jung, Sang‐Won Hong, et al.. (2012). SB365, Pulsatilla saponin D suppresses the proliferation of human colon cancer cells and induces apoptosis by modulating the AKT/mTOR signalling pathway. Food Chemistry. 136(1). 26–33. 46 indexed citations
19.
Hong, Sang‐Won, Kyung Hee Jung, Hee‐Seung Lee, et al.. (2012). SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway. Cancer Science. 103(11). 1929–1937. 45 indexed citations
20.
Li, Guangyong, Kyung Hee Jung, Hyunseung Lee, et al.. (2012). A novel imidazopyridine derivative, HS-106, induces apoptosis of breast cancer cells and represses angiogenesis by targeting the PI3K/mTOR pathway. Cancer Letters. 329(1). 59–67. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li-Yuan Bai Breakdown of academic impact, for papers by Lantu Gou Breakdown of academic impact, for papers by Xianzhi Meng Breakdown of academic impact, for papers by Haolan Wang Breakdown of academic impact, for papers by Haijun Zhang Breakdown of academic impact, for papers by Dongkyoo Park Breakdown of academic impact, for papers by Zhiyi Liu Breakdown of academic impact, for papers by Céline Van Themsche Breakdown of academic impact, for papers by Sanchita Rauth
Rankless by CCL
2026